Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AA23	TYSABRI	BioTech	Natalizumab - 300mg/15ml	300mg/15ml	Injectable concentrated solution	126,830,594 L.L
P02DA01	TAENIASAN	G	Niclosamide - 500mg	500mg	Tablet	94,709 L.L
P02DA01	TENIADEX	G	Niclosamide - 500mg	500mg	Tablet	70,392 L.L
L01EA03	TASIGNA	B	Nilotinib - 150mg	150mg	Capsule	323,961,910 L.L
L01EA03	TASIGNA	B	Nilotinib - 150mg	150mg	Capsule	L.L
L01EA03	TASIGNA	B	Nilotinib - 200mg	200mg	Capsule	412,535,139 L.L
L01EA03	TASIGNA	B	Nilotinib - 200mg	200mg	Capsule	L.L
C01DA02	TRINITRINA	G	Nitroglycerine - 50mg/50ml	50mg/50ml	Injectable concentrate for solution	6,212,584 L.L
R05FA02	TUSCALMAN B	B	Noscapine HCl - 10mg, Guaifenesin - 50mg		Suppository	615,992 L.L
R05FA02	TUSCALMAN A	B	Noscapine HCl - 5mg, Guaifenesin - 25mg		Suppository	624,963 L.L
G01AA51	TERGYNAN	G	Nystatin - 100000IU, Neomycin (sulfate) - 65000IU, Metronidazole - 500mg		Tablet	348,055 L.L
R05X	TRIMEDIL FORTE	G	O-(ß-hydroxyethyl)-rutosides - 30mg, Ascorbic acid - 80mg, Dimethindene - 0.5mg, Phenylephrine HCl - 2.5mg, Paracetamol - 200mg		Capsule	386,515 L.L
A04AA01	TRONDAMET	G	Ondansetron (HCl) - 4mg/2ml	4mg/2ml	Injectable solution	2,027,858 L.L
A04AA01	TRONDAMET	G	Ondansetron (HCl) - 8mg/4ml	8mg/4ml	Injectable solution	2,027,858 L.L
J05AH02	TAMIFLU	B	Oseltamivir (phosphate) - 75mg	75mg	Capsule	1,464,788 L.L
J05AH02	TAMIFLU	B	Oseltamivir (phosphate) - 75mg	75mg	Capsule	1,464,788 L.L
L01EB04	TAGRISSO	B	Osimertinib - 80mg	80mg	Tablet, film coated	603,192,941 L.L
L01EB04	TAGRISSO	B	Osimertinib - 80mg	80mg	Tablet, film coated	L.L
R06AD08	TOPLEXIL	B	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup	615,480 L.L
N05AX13	TREVICTA	B	Paliperidone - 175mg	175mg	Injectable suspension, prolonged release	35,006,953 L.L
N05AX13	TREVICTA	B	Paliperidone - 263mg	263mg	Injectable suspension, prolonged release	40,713,332 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	50,113,800 L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	75,169,378 L.L
N02BE01	TYLENOL	B	Paracetamol - 100mg	100mg	Suppository	190,826 L.L
N02BE01	TYLENOL	B	Paracetamol - 200mg	200mg	Suppository	235,172 L.L
N02BE01	TYLENOL	B	Paracetamol - 350mg	350mg	Suppository	239,204 L.L
M03BB52	TRANCODEX	G	Paracetamol - 450mg, Chlormezanone - 100mg		Tablet	99,828 L.L
C09BX01	TRIPLIXAM	B	Perindopril arginine - 10mg, Indapamide - 2.5mg, Amlodipine - 10mg		Tablet, film coated	1,315,622 L.L
C09BX01	TRIPLIXAM	B	Perindopril arginine - 10mg, Indapamide - 2.5mg, Amlodipine - 5mg		Tablet, film coated	1,237,679 L.L
C09BX01	TRIPLIXAM	B	Perindopril arginine - 5mg, Indapamide - 1.25mg, Amlodipine - 5mg		Tablet, film coated	968,910 L.L

...